M&A Deal Summary

PCM Trials Acquires Emvenio Research

On February 23, 2024, PCM Trials acquired life science company Emvenio Research

Acquisition Highlights
  • This is PCM Trials’ 2nd transaction in the Life Science sector.
  • This is PCM Trials’ 1st transaction in the United States.
  • This is PCM Trials’ 1st transaction in North Carolina.

M&A Deal Summary
Date 2024-02-23
Target Emvenio Research
Sector Life Science
Buyer(s) PCM Trials
Deal Type Add-on Acquisition
Advisor(s) B.C. Ziegler and Co. (Financial)

Target

Emvenio Research

Durham, North Carolina, United States
Emvenio Research is a decentralized research organization (DRO) providing scalable and hybrid decentralized trial solutions with a focus on improving access and health equity in clinical research. Emvenio Research is based in Durham, North Carolina.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

PCM Trials

Denver, Colorado, United States
Category Company
Founded 2008
Sector Healthcare Services
DESCRIPTION

PCM Trials provides decentralized clinical trials by bringing clinical research to patients, wherever and whenever it is most convenient for them. PCM Trials directly recruits, trains, certifies, and manages Certified Mobile Research Nurses (CMRNs) to ensure that each visit meets the highest standards for data quality and patient experience. PCM Trials was founded in 2008 and is based in Denver, Colorado.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 2 of 2
State (North Carolina) 1 of 1
Country (United States) 1 of 1
Year (2024) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-01-10 Clinical Trial Service

Losser, Netherlands

Clinical Trial Service is a clinical research company, based in Losser, Netherlands.

Buy -
Mergr

Product

Company

Legal